Neuroendocrine neoplasms of the larynxSamuel Mark Overholt; Donald T. Donovan; Mary R. Schwartz; Rodolfo Laucirica; Linda K. Green; Bobby R. Alford · 1995

Lentiviral transduction of murine oligodendrocytes in vivoSally R. McIver; Chul-Sang Lee; Jin-Moo Lee; Steven H. Green; Mark S. Sands; B. Joy Snider; Mark P. Goldberg · 2005

Synergistic interaction between topotecan and microtubule-interfering agentsHamid R. Bahadori; Mark R. Green; Carlo V. Catapano · 2001

ReplyMark S. Baron; Jerrold L. Vitek; Roy A. E. Bakay; Joanne Green; Yoshiki Kaneoke; Takao Hashimoto; Robert S. Turner; John L. Woodard; Steven A. Cole; William M. McDonald; Mahlon R. Delong · 1997

ReplyMark S. Baron; Jerrold L. Vitek; Roy A. E. Bakay; Joanne Green; Yoshiki Kaneoke; Takao Hashimoto; Robert S. Turner; John L. Woodard; Steven A. Cole; William M. McDonald; Mahlon R. Delong · 1997

Chemotherapy of head and neck cancerDr. Mark R. Green · 1978

Irinotecan for malignant mesotheliomaKindler, Hedy L.; Herndon, James E.; Zhang, Chunfeng; Green, Mark R. · Lung Cancer · 2005

Table of ContentsShah, Manan; Winfree, Katherine B.; Peterson, Patrick; Gruschkus, Stephen K.; Eaddy, Michael; Green, Mark R. · Journal of Renal Nutrition · 2007